Cambridge Network & MedImmune event: The necessity of digital health in treating respiratory diseases

Brought to you by Cambridge Network

This event will explore the necessity of digital health for respiratory diseases. With digital technologies set to disrupt the healthcare sector in the future, Medimmune recognises this opportunity, and is looking to position itself as a leader in digital adoption in their pipeline and beyond.

About the event

Focusing on respiratory disease this event will explore where digital health could have an impact in generating novel endpoints that give greater insight into disease progression and management. The keynote talk will be given by arm onEnabling Digital Health, with supporting talks from Owlstone MedicalMologic and Pneumacare along with the finalists from the Digital Health Challenge.

Have you developed - or are you looking to create - a healthcare solution based on digital technology? If so, you stand the chance of winning £20,000 and mentoring opportunities from MedImmune - winners to be announced at this event. Details can be found in the attached flyer (see 'related document' near the Book Now button, above) or here.

Agenda

Digital Health MedImmune

1.45pm

Registration

2pm

Welcome and introduction

Jane Osbourn, Vice President, R&D, MedImmune

Jane Osbourn, MedImmune

2.10pm

René van der Merwe, VP Clinical RespiratoryMedImmune

Rene van der Merwe

2.20pm

Keynote talk: Enabling Digital Health - ARM

Mobile technology is fully integrated into our daily lives; so how do we translate this into smart digital devices for proactive healthcare and pharmaceutical advancement? This presentation will challenge and discuss the barriers that exist to realizing the full benefits of patient connectivity at scale, and show how digital health will impact our not-so-distant future

Speaker: Peter Ferguson, Director of Healthcare Technologies

ARM

2.50pm

Breath Biopsy - VOCs biomarkers in early detection and precision medicine

Every time you breathe out there are thousand of chemicals on your breath called volatile organic compounds or VOCs. Some of these VOCs are biomarkers of disease in everything ranging from cancer to inflammatory and infectious disease. We'll discuss how Breath Biopsy technology can be used in early detection and precision medicine applications.

Speaker: Billy Boyle, Owlstone

Billy Boyle, Owlstone Medical

3.10pm

The message in the bottle…….of urine!

Most of the biomarkers we find in urine originate in the lungs and are processed through the kidneys. Consequently, we can learn much about what’s going in the lungs and how the kidneys are responding to the presence of high levels of inflammatory mediators (including proteases) escaping from the lung into the blood.  Mologic is busy developing ways to accurately determine the biomarker profiles by simple, patient-friendly technology, and to translate the resultant digital health data into simple diagnostic conclusions and triggering of interventions.

Speaker: Prof Paul Davis, Chief Scientific Officer

Mologic

3.30pmPneumacare

PneumaCare’s mission is to provide revolutionary imaging technologies that increase efficient and effective patient care with a vision of becoming the market leader in non-contact, non-invasive imaging technology.
PneumaCare is a Cambridgeshire (UK)-based company providing clinicians with unique non-invasive ways of observing active, real-time regional respiratory function via chest wall movement. It provides the capability for clinicians to assess respiratory function in all patients including previous inaccessible groups, whether young or old, conscious or unconscious, sitting or lying down; and its use does not require any contact or direct interaction with the patient.

Speaker: Paul Reynard, COO

3.50pm

Break

4.10pm

The Digital Health Technology Challenge for Entrepreneurs

These entrepreneurs have a passion for creating novel digital solutions to solve drug development’s most difficult problems. Five finalists will have a chance to win the grand prize by presenting to a panel of prominent industry funding experts and executives:

  • Jane Osbourn, Vice President, R&D, MedImmune
  • Rene van der Merwe, Vice President, Clinical Development, MedImmune
  • Andy Williams, Vice President, Strategy and Operations, AstraZeneca
  • Debu Purkayastha, Managing Partner, 3rd Eye Capital
  • Andrew Chapman, Digital Health Sector Lead, Digicatapult

To enter the awards:

Details to be advertised shortly: please email louise.rushworth@cambridgenetwork.co.uk

5.10pm

Q&A for the speakers

5.25pm

Closing remarks and the results of the Tech Challenge announced

5.30pm

Networking over light refreshments

6.30pm

End

You can follow @cambnetwork on Twitter.

Event Location

Open in google maps

Location info

Hauser Forum, The Entrepreneurship Centre, 3 Charles Babbage Road, CB3 0GT

Email organiser

Related events

  • Cambridge Network

    Interviewing Skills

    Register now
  • Cambridge Network

    Coaching: An Introduction

    Register now
  • Cambridge Network

    Train the Trainer

    Register now

Subscribe to the CW newsletter

This site uses cookies.

We use cookies to help us to improve our site and they enable us to deliver the best possible service and customer experience. By clicking accept or continuing to use this site you are agreeing to our cookies policy. Learn more

Reserve your place

Sign in to your account

Please sign in to your CW account to reserve a place for this event. also add multiple attendees from your organisation

Join the CW network

CW is a leading and vibrant community with a rapidly expanding network of nearly 400 companies across the globe interested in the development and application of wireless and mobile technologies to solve business problems.

Start typing and press enter or the magnifying glass to search